| |
|
|
|
United Nations University's Programme for Biotechnology in Latin America and the Caribbean (UNU-BIOLAC), Permanent Mission of Germany to the United Nations, 48th Street and 1st avenue, New York, NY 10017
October 28th, 2004
This event is an opportunity to introduce and present the work and research of the United Nations University's Programme for Biotechnology for Latin American and the Caribbean (UNU-BIOLAC), based in Caracas, Venezuela. UNU-BIOLAC does extensive capacity development, with the aim of promoting the use of biotechnology for development and integration in the region. Beyond this, our high-profile panelists will discuss the burden of infectious diseases in Latin America, the solutions available to tackle this problem, and the tools needed to empower local populations and scientists.
|
|
|
|
|
|
|
|
Organized by:
|
|
United Nations University |
|
|
Invited Speakers:
|
|
Dr. José Luis Ramirez, Coordinator, UNU-BIOLAC Dr. Gerald Keusch, Assistant Provost for Global Health, Boston University Medical Campus and Associate Dean for Global Health at Boston University School of Public Health Dr. Stephen L. Hoffman, the founder and Chief Executive and Scientific Officer of Sanaria Inc., and co-founder and Chairman of Protein Potential LLC, vaccine development companies in Rockville, MD.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
|
|
|
|
|
|
|
|
Registration:
|
|
If you wish to attend, please register online at http://www.ony.unu.edu/unuseminarregistration.htm. For further information please call UNU Office in NY at 212-963-6387.
|
|
|
E-mail:
|
|
ramon@ony.unu.edu, nassim@ony.unu.edu
|
|
|
|
|
|
|
|
|